Boksörlerde Yüksek Şiddetli İnterval Antrenmanın AerobikKapasite Üzerine Etkisi
Journal of Sports, Health and Education Research · 01.01.2023
DOI: 10.13140/rg.2.2.34956.90244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sports, Health and Education Research, erschienen am 01.01.2023. Verfasst von Şahin und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Aim: The aim of this study was to investigate the effect of high-intensity interval training on aerobic capacity in boxers. Materials and Methods: A total of 18 male students voluntarily participated in the study, who were enrolled in the Hasan Doğan School of Physical Education and Sports at Karabük University and engaged in boxing sports. Participants were randomly divided into two groups: an experimental group (average age 23.22±1.71 years, average height 1.75±0.05 m, average body weight 72.32±8.98 kg) and a control group (average age 22.44±1.74 years, average height 1.74±0.07 m, average body weight 72.07±13.29 kg), consisting of 9 individuals each. The experimental group, in addition to their routine training, participated in a high-intensity interval training program for 6 weeks, three days a week. The control group continued their regular training. As the data showed a normal distribution, the paired t-test was used to compare the pre-test and post-test values. A confidence interval of p
Schlagwörter
Zitieren
APA
Şahin, & Musa (2023). Boksörlerde Yüksek Şiddetli İnterval Antrenmanın AerobikKapasite Üzerine Etkisi. Journal of Sports, Health and Education Research. https://doi.org/10.13140/rg.2.2.34956.90244
Vancouver
Şahin, Musa. Boksörlerde Yüksek Şiddetli İnterval Antrenmanın AerobikKapasite Üzerine Etkisi. Journal of Sports, Health and Education Research. 2023. doi:10.13140/rg.2.2.34956.90244
BibTeX
@article{ahin2023,
author = {Şahin and Musa},
title = {Boksörlerde Yüksek Şiddetli İnterval Antrenmanın AerobikKapasite Üzerine Etkisi},
journal = {Journal of Sports, Health and Education Research},
year = {2023},
doi = {10.13140/rg.2.2.34956.90244}
}
EUVIMED